NCCNガイドラインでオプチューンが初発膠芽腫の標準的治療の選択肢として推奨される
ジャージー島セントへリア (ビジネスワイヤ) — ノボキュア社(NASDAQ: NVCR)は本日、全米総合がん情報ネットワーク(NCCN)が中枢神経系がんの腫瘍診療ガイドライン(NCCNガイドライン)で、オプチューンを初発膠芽腫(GBM)の標準的治療の選択肢として推奨したと発表しました。...
View ArticleTakeda Receives Marketing Authorization in Canada for NINLARO™ (ixazomib) in...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced Takeda Canada has received approval from Health Canada for NINLARO™ (ixazomib) capsules in...
View ArticleAcucela Announces Official Name of Acucela Japan as Kubota Pharmaceutical...
SEATTLE Acucela Inc. (Tokyo: 4589) (the “Company”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleAward-winning Journalist David O’Shea Joins This Year’s Experts at the 2016...
MADISON, Wis. The largest international conference on DNA analysis for human identification, the 27th International Symposium on Human Identification (ISHI) will feature presentations from leading...
View ArticleOutcomes of Presbia Microlens Surgeries in Korean Study Demonstrate Excellent...
DUBLIN Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near-vision restoration, announced the 12-month results of the 14 Presbia Flexivue Microlens™ surgeries performed on...
View ArticleCANbridge Signs Agreement with Boehringer Ingelheim to Manufacture Inhibitory...
SHANGHAI Boehringer Ingelheim and CANbridge Life Sciences announced that both parties have signed an agreement for the manufacture of CAN-017, an ErbB3 (HER3) inhibitory antibody to treat esophageal...
View ArticlePromega Maxwell® RSC Advances High Quality Sample Prep for Food Testing
MADISON, Wis. The launch of the Maxwell® RSC PureFood GMO* and Authentication Kit for food testing delivers automated high quality sample prep for food testing labs. The Maxwell RSC PureFood GMO and...
View ArticlePromega 2016 Corporate Responsibility Report Highlights Initiatives...
MADISON, Wis. The latest publication of the Promega Corporate Responsibility Report focuses on the organization’s thoughtful growth through expansion of energy-efficient facilities, advances in...
View Articleピラマル・エンタープライゼズが高活性原薬(HPAPI)の米国CDMOアッシュ・スティーブンスを買収する契約を締結
印ムンバイ (ビジネスワイヤ) — ピラマル・エンタープライゼズ・リミテッド (PEL、NSE: PEL、BSE:...
View ArticleSAB Biotherapeutics Announces Contract with BARDA to Advance First MERS...
SIOUX FALLS, S.D. SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company, announced today that it has been awarded a contract for up to $5.3 million by the...
View Article武田薬品: 医薬品アクセス(Access to Medicines)に関する新たな取り組みについて
大阪 (ビジネスワイヤ) — 当社は、このたび、アンメットメディカルニーズの高い患者さんを対象に、生命を救う可能性のある当社の革新的な医薬品に対するアクセスを改善することを目的として、医薬品アクセス(Access to...
View ArticleTakeda Announces Bold, New Access to Medicines Strategy
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502) today announced the launch of a bold, new Access to Medicines (AtM) strategy, aimed at increasing access to its innovative and...
View ArticleSciBase: New Study: Swedish Nevisense Can Reduce Follow-up Visits by Half for...
STOCKHOLM SciBase (STO:SCIB) A new Australian study, using the Swedish instrument Nevisense, showed it is possible to reduce the number of cases that require digital dermoscopy follow-up by almost...
View ArticleZRG Partners Releases Q2 2016 Global Life Sciences Hiring Index
ROCHELLE PARK, N.J. ZRG Partners has announced the findings for the second quarter Global Life Sciences Hiring Index. 2016 has shown an increase in hiring demand consistently, posting 50% higher...
View ArticleMasimo Announces Four-Year Partnership with World Federation of Societies of...
IRVINE, Calif. & HONG KONG Masimo (NASDAQ: MASI) announced Sunday at the World Congress of Anaesthesiologists (WCA) in Hong Kong that it has become the first Global Impact Partner of the World...
View Article武田发布宏伟的全新药品获取战略
日本大阪 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)今天宣布启动一项宏伟的全新药品获取(Access to Medicines, AtM)战略,旨在使面临部分最紧迫的未获满足医疗需求的患者增加获取有望挽救生命的武田创新药品。数十年来,该公司依据地区性的需求,已在世界许多地方提供产品、经费和获取。新的AtM战略以此为基础,专注于面临最紧迫的未获满足需求的地区和治疗领域。...
View ArticleMasimo发布针对寨卡病毒肆虐地区总血红蛋白(SpHb®)监测的特别全球项目
加州尔湾 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布,为了回应寨卡病毒及其对血制品可及性的潜在影响,Masimo正在创立一个特别项目,以大幅降低 Masimo的连续血红蛋白监测(SpHb®)解决方案的成本、增加其获取,研究显示,该方案可帮助临床医生减少低失血量和高失血量手术中的输血量。该特别项目将适用于血液供应受寨卡病毒影响的所有地区。...
View ArticleGORE® DrySeal Flex Introducer Sheath Advances Care through Access
FLAGSTAFF, Ariz. W. L. Gore & Associates, Inc. (Gore) today announced the commercial availability of the GORE® DrySeal Flex Introducer Sheath, after recently gaining clearance for use by...
View ArticleMasimo宣布与世界麻醉师学会联盟(WFSA)缔结为期4年的伙伴关系
加州尔湾和香港 (美国商业资讯) — Masimo (NASDAQ: MASI)星期天在香港召开的世界麻醉师大会(WCA)上宣布,该公司已成为世界麻醉师学会联盟(WFSA)的首个全球影响伙伴。该伙伴关系名为“Safe Anaesthesia – ASAP”(麻醉安全行动计划),首先将确定一个难以获取安全麻醉的国家,然后协同落实一些旨在改善麻醉医护和安全手术转归的项目和培训。...
View ArticleGORE® DrySeal Flex Introducer Sheathはアクセス改善で治療を前進
米アリゾナ州フラッグスタッフ (ビジネスワイヤ) — W. L. Gore & Associates, Inc.(ゴア)は本日、米国・欧州・カナダ・オーストラリアの規制当局から最近承認されたことを受け、GORE® DrySeal Flex Introducer...
View Article